Immediate Impact
24 standout
Citing Papers
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
2025 Standout
AXL signaling in cancer: from molecular insights to targeted therapies
2025 Standout
Works of Branko Cuglievan being referenced
The Menin Inhibitor SNDX-5613 (revumenib) Leads to Durable Responses in Patients (Pts) with KMT2A-Rearranged or NPM1 Mutant AML: Updated Results of a Phase (Ph) 1 Study
2022
Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Branko Cuglievan | 192 | 119 | 107 | 125 | 73 | 525 | |
| Aurora Medina‐Sansón | 191 | 141 | 79 | 103 | 40 | 646 | |
| Chitose Ogawa | 161 | 176 | 171 | 124 | 78 | 640 | |
| Hyery Kim | 140 | 143 | 191 | 70 | 94 | 631 | |
| Vivek A. Bhadri | 186 | 137 | 84 | 156 | 33 | 550 | |
| Mike G. Martin | 236 | 114 | 160 | 122 | 34 | 558 | |
| Katarzyna Drabko | 83 | 71 | 105 | 187 | 75 | 464 | |
| Donald K. Strickland | 154 | 114 | 130 | 72 | 36 | 646 | |
| Kyung‐Nam Koh | 146 | 72 | 282 | 89 | 79 | 617 | |
| Annalisa Serra | 78 | 59 | 132 | 94 | 46 | 504 | |
| Shilpa Paul | 222 | 188 | 280 | 80 | 41 | 633 |
All Works
Login with ORCID to disown or claim papers
Loading papers...